Infections with beta-Hemolytic Streptococcus resistant to lincomycin and erythromycin and observations on zonal-pattern resistance to lincomycin.
D000416:Alberta; D002170:Canada; D003470:Culture Media; D004196:Disease Outbreaks / Q000453:epidemiology*; D004352:Drug Resistance, Microbial; D004917:Erythromycin / Q000494:pharmacology*; D006801:Humans; D008034:Lincomycin / Q000494:pharmacology*; D008826:Microbial Sensitivity Tests; D012703:Serotyping; D013290:Streptococcal Infections / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology; D013291:Streptococcus / Q000187:drug effects* / Q000302:isolation & purification; D013292:Streptococcus agalactiae / Q000187:drug effects / Q000302:isolation & purification; D013297:Streptococcus pyogenes / Q000187:drug effects* / Q000302:isolation & purification
D003470:Culture Media; D004917:Erythromycin; D008034:Lincomycin